Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.79% |
| 3 | Consumer Discretionary | 12.36% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1576
Franklin Templeton
BEN
$16.2B
| $4.61M | 0.01% |
193,200
-479,897
| -71% | -$9.89M |
2024 Q3
3 quarters
|
|
1577
iShares MSCI ACWI ex US ETF
ACWX
$17.6B
| $4.58M | 0.01% |
75,100
+56,100
| +295% | +$3.24M |
2024 Q1
5 quarters
|
|
1578
Americold
COLD
$3.98B
| $4.57M | 0.01% |
274,800
-51,800
| -16% | -$939K |
2024 Q1
5 quarters
|
|
1579
DELISTED
Eventbrite
EB
| $4.56M | 0.01% |
1,731,996
+187,200
| +12% | +$431K |
2021 Q2
16 quarters
|
|
1580
Quad
QUAD
$485M
| $4.54M | 0.01% |
804,400
+18,700
| +2% | +$101K |
2014 Q1
45 quarters
|
|
1581
Nexxen International
NEXN
$514M
| $4.54M | 0.01% |
436,400
-182,400
| -29% | -$1.85M |
2021 Q4
14 quarters
|
|
1582
iMGP DBi Managed Futures Strategy ETF
DBMF
$4.47B
| $4.54M | 0.01% |
176,400
+137,800
| +357% | +$3.49M |
2024 Q2
4 quarters
|
|
1583
JPMorgan BetaBuilders Japan ETF
BBJP
$19.6B
| $4.53M | 0.01% |
+73,400
| New | +$4.28M |
2025 Q2
0 quarters
|
|
1584
Empire State Realty Trust
ESRT
$819M
| $4.53M | 0.01% |
560,000
+16,100
| +3% | +$123K |
2024 Q1
5 quarters
|
|
1585
Community Health Systems
CYH
$412M
| $4.52M | 0.01% |
1,329,393
+654,200
| +97% | +$2.1M |
2022 Q3
11 quarters
|
|
1586
DELISTED
TruBridge
TBRG
| $4.52M | 0.01% |
+192,876
| New | +$4.73M |
2025 Q2
0 quarters
|
|
1587
Marcus Corp
MCS
$847M
| $4.51M | 0.01% |
267,789
-121,800
| -31% | -$2.06M |
2021 Q4
14 quarters
|
|
1588
Invesco S&P 500 Momentum ETF
SPMO
$22.9B
| $4.51M | 0.01% |
+40,100
| New | +$4M |
2025 Q2
0 quarters
|
|
1589
Kayne Anderson BDC
KBDC
$823M
| $4.49M | 0.01% |
294,500
-93,200
| -24% | -$1.47M |
2024 Q3
3 quarters
|
|
1590
Ingles Markets
IMKTA
$1.62B
| $4.49M | 0.01% |
70,884
-23,900
| -25% | -$1.49M |
2019 Q2
24 quarters
|
|
1591
Worthington Steel
WS
$1.9B
| $4.48M | 0.01% |
150,300
-1,700
| -1% | -$43.8K |
2024 Q1
5 quarters
|
|
1592
Electromed
ELMD
$233M
| $4.45M | 0.01% |
202,204
+50,900
| +34% | +$1.11M |
2017 Q3
31 quarters
|
|
1593
Atea Pharmaceuticals
AVIR
$403M
| $4.44M | 0.01% |
1,234,100
-44,300
| -3% | -$132K |
2021 Q3
15 quarters
|
|
1594
Rigel Pharmaceuticals
RIGL
$912M
| $4.43M | 0.01% |
236,446
+35,300
| +18% | +$669K |
2021 Q4
14 quarters
|
|
1595
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $4.43M | 0.01% |
+91,800
| New | +$4.13M |
2025 Q2
0 quarters
|
|
1596
Viant Technology
DSP
$279M
| $4.43M | 0.01% |
334,700
-87,900
| -21% | -$1.2M |
2021 Q3
15 quarters
|
|
1597
DELISTED
HarborOne Bancorp
HONE
| $4.42M | 0.01% |
378,300
-57,541
| -13% | -$629K |
2017 Q2
32 quarters
|
|
1598
TechTarget
TTGT
$278M
| $4.41M | 0.01% |
568,100
+45,500
| +9% | +$362K |
2013 Q2
48 quarters
|
|
1599
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45B
| $4.41M | 0.01% |
+10,000
| New | +$4.15M |
2025 Q2
0 quarters
|
|
1600
First Bancorp
FBP
$4.08B
| $4.4M | 0.01% |
211,413
+180,600
| +586% | +$3.55M |
2024 Q4
2 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2025 Portfolio in Review
As of Q2 2025, Renaissance Technologies held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Renaissance Technologies added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Renaissance Technologies's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Renaissance Technologies fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Renaissance Technologies's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Renaissance Technologies opened 612 new positions and closed 496 in Q2 2025.
- Renaissance Technologies's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.